ArticleHeliyon2022
Characterization of levansucrase produced by novel
Article in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 18 citations in OpenAlex.
- Extraction, characterization, and toxicity evaluation of levan from marine bacterium Priestia aryabhattai LEV207 using brine shrimp model.Archives of microbiology · 2026Article
- Dynamic metabolic modeling uncovers systems-level strategies to simultaneously maximize levan yield and substrate efficiency in Bacillus subtilis LY7.16.PLoS computational biology · 2026Article
- Scaling EPS yield and bio-carrier application ofPeerJ · 2026Article
- Analysis of cultivation conditions and enzymatic efficiency enables high-yield levan production from Bacillus velezensis KKSB6.Bioresources and bioprocessing · 2025Article
- Optimization of levan biosynthesis fromBiotechnology reports (Amsterdam, Netherlands) · 2025Article
- Biopolymer-Levan Characterization inACS omega · 2025Article
- Novel Haloalkaliphilic Nitrile-Degrading Bacteria From Soda Lake Soil of Rift Valley Kenya.TheScientificWorldJournal · 2025Article
- Levan Production byMolecules (Basel, Switzerland) · 2024Article
- Exopolysaccharides Producing Bacteria: A Review.Microorganisms · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Levan has attracted interest due to the potential health benefits associated with its prebiotic, biological, and functional properties. However, the production of levan is expensive due to its high resource requirements. With the growing demand for levan, it is vital to determine suitable cultivation condition for its production and reduce costs accordingly. The present study characterized the enzyme levansucrase produced by a novel strain of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.